📰 Mina Sooch News
Page 2 - Mina Sooch News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Mina Sooch. Real-time updates on events, politics, business and more.
March 29, 2022
Ocuphire Announces Positive Topline Results from MIRA-3 Phase 3 FDA Registration Trial for Nyxol® in the Reversal of Mydriasis - read this article along with other careers information, tips and advice on BioSpace
March 24, 2022
Ocuphire Announces Financial Results for the Fourth Quarter and Year Ended 2021 and Provides Corporate Update Building Momentum with Completion of Patient... | March 24, 2022
March 10, 2022
10.03.2022 - FARMINGTON HILLS, Mich., March 10, 2022 (GLOBE NEWSWIRE) - Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of refractive and retinal ...
January 31, 2022
New data support Phase 3 development of Nyxol alone as a durable single eye drop for the potential treatment of Presbyopia First update on recruitment in APX3330 ZETA-1 Phase 2b trial: ~70% patients... | January 31, 2022
December 8, 2021
FARMINGTON HILLS, Mich, Dec. 08, 2021 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company...
June 11, 2021
Dr. Pepose is Recognized as an Esteemed Key Opinion Leader in Ophthalmology with Nearly 40 Years of Experience as a Leading Clinical Researcher and...
May 20, 2021
Highlights of Recent Positive Data from Nyxol's Phase 3 Registration Trial Roundtable Discussion by 3 KOLs with Unique Perspectives and Distinct Patient ...
February 21, 2021
Webcast examines post-pandemic M&A outlook Crains Detroit Business Laura Marcero. The pandemic reshaped mergers and acquisitions in 2020, but it didnt halt them. Crains will take a look back at the deals of 2020 and what to expect in 2021 in M&A trends in a webcast at 3:30 p.m. March 10. Senior reporter Dustin Walsh will host a series of conversations with guests including: Mina Sooch, CEO and co-founder, Ocuphire Pharma Inc. Greg Lehmkuhl, president and CEO, Lineage Logistics Rajesh U. Kothari...
January 6, 2021
Ocuphire Pharma Initiates LYNX-1 Phase 3 Study Investigating Nyxol in Night Vision Disturbances January 05, 2021 07:00 ET | Source: Ocuphire Pharma Ocuphire Pharma Nyxol is in Late Stage Clinical Development for A New Ophthalmic Indication Top Line Data from LYNX-1 Expected 3Q2021 FARMINGTON HILLS, Mich., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializi...